Literature DB >> 28374327

Scintigraphic findings in end-stage liver disease on Tc-99m sestamibi SPECT/CT myocardial perfusion imaging.

Tarun Jain1, N T K Thanseer1, Ashwani Sood2, Madan Parmar1, Anish Bhattacharya1, Bhagwant Mittal1.   

Abstract

Technetium-99m sestamibi myocardial perfusion imaging is commonly employed non-invasive study for evaluation of coronary artery disease; however, incidental extracardiac scintigraphic findings observed may provide additional diagnostic information. The authors present the unusual scintigraphic findings in a case of decompensated liver disease with right hepatic hydrothorax, being planned for orthotopic liver transplant.

Entities:  

Keywords:  Liver cirrhosis; Liver transplant; Myocardial perfusion imaging; Sestamibi; Technetium-99m

Mesh:

Substances:

Year:  2017        PMID: 28374327     DOI: 10.1007/s12350-017-0870-7

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  3 in total

1.  Cardiac work-up protocol for liver transplant candidates: experience from a single liver transplant centre.

Authors:  Carrie Ye; Meghana Saincher; Puneeta Tandon; Glenda Meeberg; Randy Williams; Kelly W Burak; Vincent G Bain
Journal:  Can J Gastroenterol       Date:  2012-11       Impact factor: 3.522

2.  Scintigraphic demonstration of a diaphragmatic defect as the cause of massive hydrothorax in cirrhosis.

Authors:  A Serena; L Aliaga; J A Richter; R Calderon; L Sanchez; M A Charvet
Journal:  Eur J Nucl Med       Date:  1985

3.  The prevalence of coronary artery disease in liver transplant candidates over age 50.

Authors:  W D Carey; J A Dumot; R R Pimentel; D S Barnes; R E Hobbs; J M Henderson; D P Vogt; J T Mayes; M K Westveer; K A Easley
Journal:  Transplantation       Date:  1995-03-27       Impact factor: 4.939

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.